Novo Nordisk vs Orchard Therapeutics
Novo Nordisk vs Orchard Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Novo Nordisk is on 26/100 and Orchard Therapeutics on 51/100.
Where each one leads
Novo Nordisk
- domain rating: 80/100 against 60/100
- headcount: 62,380 against 248
- LinkedIn following: 2,840,043 against 54,964
Orchard Therapeutics
- our overall score: 51/100 against 26/100
At a glance
| Measure | Novo Nordisk | Orchard Therapeutics |
|---|---|---|
| What it is | Global healthcare company focused on diabetes care, obesity, and rare blood disorders. | Gene therapy company developing treatments for rare inherited diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 1923 | 2015 |
| Headquarters | Bagsværd, Denmark | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Novo Nordisk | Orchard Therapeutics |
|---|---|---|
| Employees | 62,380 | 248 |
| Total funding | Not published | $125M |
| Latest round | Not published | IPO |
| LinkedIn followers | 2,840,043 | 54,964 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Novo Nordisk | Orchard Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 26/100 | 51/100 |
| Traction | 20/100 | 60/100 |
| Team | 10/100 | 30/100 |
| Search visibility | 52/100 | 25/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 80/100 | 60/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Novo Nordisk | Orchard Therapeutics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager |
What users say
| Measure | Novo Nordisk | Orchard Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 4 negative across 6 threads | Not published |
“Novo-Nordisk is the second-largest pharmaceutical company in the diabetes/obesity market, behind competitor Eli Lilly. Its m”r/ValueInvesting
Novo Nordisk vs Orchard Therapeutics: common questions
Which is better, Novo Nordisk or Orchard Therapeutics?
On our 0-100 score Orchard Therapeutics rates higher (51/100 against 26/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Novo Nordisk and Orchard Therapeutics compare on the numbers?
Novo Nordisk leads on domain rating (80/100 against 60/100), headcount (62,380 against 248), LinkedIn following (2,840,043 against 54,964). Orchard Therapeutics leads on our overall score (51/100 against 26/100).
What do real users say about Novo Nordisk and Orchard Therapeutics?
Novo Nordisk: 2 positive and 4 negative mentions across 6 Reddit threads we track, mostly in r/ValueInvesting.
Read the full Novo Nordisk review and pricing or the Orchard Therapeutics review and pricing. You can also browse other Novo Nordisk alternatives we track.